Valuation: Bure Equity AB

Market Cap 23.45B 2.35B 2.1B 1.96B 1.78B 3.34B 223B 3.37B 9.18B 116B 8.83B 8.64B 372B P/E 2024
4.94x
P/E 2025 -3.91x
Enterprise Value 23.11B 2.32B 2.07B 1.93B 1.75B 3.29B 220B 3.32B 9.05B 114B 8.7B 8.51B 367B EV / Sales 2024
4.74x
EV / Sales 2025 -3.91x
Free-Float
70.39%
Yield 2024
0.72%
Yield 2025 1.11%
1 day-1.15%
1 week-0.25%
Current month-0.51%
1 month+5.15%
3 months+22.35%
6 months+35.20%
Current year+27.31%
1 week 305
Extreme 305
316.6
1 month 294.8
Extreme 294.8
325
Current year 190.2
Extreme 190.2
330.6
1 year 190.2
Extreme 190.2
330.6
3 years 190.2
Extreme 190.2
421.2
5 years 171.3
Extreme 171.3
474.6
10 years 86.8
Extreme 86.8
489.2
Manager TitleAgeSince
Chief Executive Officer 55 22/04/2013
Director of Finance/CFO 58 01/10/2013
Chief Investment Officer 46 01/01/2019
Director TitleAgeSince
Director/Board Member 56 30/04/2010
Chairman 62 22/04/2013
Director/Board Member 60 04/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
21/08/26 Buy

Director

1,100 0.0015%
01/06/26 Buy

Chief Financial Officer

1,069 0.0014%
26/05/26 Buy 67,000 0.0904%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.25%+16.72%+38.90% 2.34B
+0.87%+1.22%+34.34%+88.37% 125B
+0.89%-3.04%+34.14%+74.60% 21.73B
+0.37%-0.37%+21.13%+50.18% 16.36B
+2.16%+2.95%+19.03%+147.85% 15.65B
+0.26%-0.79%+15.45%+21.50% 14.02B
-1.66%+0.59%+74.45%+95.82% 13.63B
-0.10%0.00%-11.78%+4.90% 13.05B
-0.36%+1.27%-10.82%+58.38% 12.57B
+0.93%+0.90%+18.25%+33.18% 11.99B
Average +0.23%+0.80%+21.09%+61.37% 24.65B
Weighted average by Cap. +0.67%+1.21%+27.93%+75.90%

Financials

2024 2025
Net sales 5.81B 582M 520M 485M 439M 827M 55.26B 834M 2.27B 28.74B 2.19B 2.14B 92.23B -4.6B -461M -412M -384M -348M -655M -43.79B -660M -1.8B -22.77B -1.73B -1.69B -73.07B
Net income 5.74B 576M 514M 479M 435M 818M 54.64B 824M 2.25B 28.42B 2.16B 2.11B 91.19B -4.68B -469M -419M -390M -354M -666M -44.52B -672M -1.83B -23.15B -1.76B -1.72B -74.29B
Net Debt -779M -78.1M -69.77M -65.03M -58.96M -111M -7.41B -112M -305M -3.86B -293M -287M -12.37B -339M -33.99M -30.36M -28.3M -25.66M -48.28M -3.23B -48.66M -133M -1.68B -128M -125M -5.38B
Projected Income Statement - Annual - Bure Equity AB
Logo Bure Equity AB
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Employees
12
Date Price Change Volume
13/10/26 SEK 314.20 0.00% 70,107
12/10/26 SEK 314.20 +0.71% 51,812
09/10/26 SEK 312.00 +1.10% 60,546
08/10/26 SEK 308.60 -0.19% 56,763
07/10/26 SEK 309.20 -1.84% 63,584
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. BURE Stock